Showing 1-5 of 7 networking planning:
How can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?

June 24, 2024 Pharma’s Almanac Read the full article >> Rich Gliklich, M.D., Chief Executive Officer and founder, OM1 One impactful way will be through platforms that enable data and study automation. In recent remarks, FDA Commissioner Dr. Robert Califf argued that there is tremendous opportunity to simplify and digitize data collection to create more pragmatic[…]

Expert Praises Proposed Federal Rule to Strengthen Behavioral Health Parity

HealthLeaders Christopher Cheney August 1, 2023 Read the full article >> A new proposal from the Biden administration to strengthen parity for behavioral health services with physical health services is a step in the right direction, according to Carl Marci, MD, a psychiatrist at Massachusetts General Hospital and an assistant professor of psychiatry at Harvard Medical School.[…]

OM1 Launches New Mental Health and Neuroscience Real-World Data Network

Read the Press Release>>   BOSTON, March 31, 2022 /PRNewswire/ — OM1, a leading technology enabled real-world data and artificial intelligence (AI) company with a focus on delivering insights into multiple chronic diseases, today announces the launch of its Mental Health and Neuroscience Specialty Area led by physician and entrepreneur, Dr. Carl D. Marci. The division includes new data on psychiatric[…]

Leveraging “Re-Usable” Data Networks for Prospective Research and Post Marketing Commitments

Wed, Aug 18, 2021 2:00 PM – 3:00 PM EDT Presenter: Richard Gliklich, MD, CEO, OM1 Register >> Automated, clinical ‘data networks’ are transforming the research paradigm. This webinar explores: – How do multi-purpose, ‘reusable’ data networks differ from the traditional research model, in particular for real-world evidence and patient registries? – How are data[…]